An update on invasive pneumococcal antibiotic resistance in Turkey, 2008

Journal of Chemotherapy

Volumn 20, Issue 6, 2008, Pages 697-701

  Erdem, Hakan ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Antibiotic resistance; Pneumococci; Turkey

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; CEFACLOR; CEFOTAXIME; CEFPROZIL; CEFTRIAXONE; CHLORAMPHENICOL; CLARITHROMYCIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GEMIFLOXACIN; LEVOFLOXACIN; MOXIFLOXACIN; OFLOXACIN; PENICILLIN G; RIFAMPICIN; TELITHROMYCIN; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; CONTROLLED STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PENICILLIN RESISTANCE; QUANTITATIVE ANALYSIS; STREPTOCOCCUS PNEUMONIAE; TURKEY (REPUBLIC);

EID: 59349087249     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2008.20.6.697     Document Type: Article

References (30)

1. Erdem H, Pahsa A. Antibiotic resistance in pathogenic Streptococcus pneumoniae isolates in Turkey J Chemother. 2005;17(1):25-30.
2. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial tests: bacteria that grow aerobically. 7 ed 2006.
3. Yenisehirli G, Sener B. Antibiotic resistance and serotype distribution of Streptococcus pneumoniae strains isolated from patients at Hacettepe University Medical Faculty Mikrobiyol Bul. 2003;37(1-11).
4. Altun B, Gur D, Kocagoz S, Hascelik G, Unal S. Molecular epidemiology of penicillin resistant Streptococcus pneumoniae strains in Turkey. A multicenter study. Annals Microbiol. 2006;56(3):185-90.
5. Senol G, Erer OF, Bicmen C, Aktogu S. Alt solunum yolu infeksiyonlarindan izole edilen S. pneumoniae suslarinin penisiline karsi direnc oranlari (The penicillin resistance rates of S pneumoniae strains isolated from lower respiratory tract infections). Toraks Derg. 2001;2(3):10-5.
6. Kucukbasmaci O, Gonullu N, Aktas Z, Gurol D, Berkiten R. In vitro activity of telithromycin compared with macrolides and fluoroquinolones against Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis. Int J Antimicrob Agents. 2003;22(5):497-501:.
7. Tanir G, Karacan C, Topal H, Özkan S. Streptococcus pneumoniae'nin cocukluk doneminde etken oldugu invazif infeksiyonlar ve antibiyotiklere karsi direnc durumu (The invasive infections in childhood due to S. pneumoniae and the antibiotic susceptibility patterns). Klimik Derg. 2003; 16(2):79-84.
8. Oncu S, Punar M, Eraksoy H. Comparative activities of beta-lactam antibiotics and quinolones for invasive Streptococcus pneumoniae isolates. Chemotherapy. 2004;50(2):98-100.
9. Sener B, Koseoglu O. Comparative in vitro activity of antiribosomal agents on penicillin-susceptible and resistant Streptococcus pneumonioe in relation to their resistance genotypes. Int J Med Microbiol 2004;24(1):39-42.
10. Bicmen M, Gülay Z. Antibiotic susceptibility patterns and molecular epidemiology of S. pneumoniae in Izmir Turkey. Clin Microbiol Infect. 2003;9(Suppl 1):356.
11. Erdem H, Öncül O, Çavuslu S, Pahsa A. Sivas bolgesinde hastalik etkeni pnomokoklarda direnc (Antibacterial resistance in invasive pneumococci in Sivas Region). Klimik Derg. 2002;15(2):46-8.
12. Tuncer I, Arslan U, Findik D, Ural O. Klinik orneklerden izole edilen Streptococcus pneumoniae suslarinda artan penisilin direnci ve bazi antibiyotiklere karsi direnc durumu (increasing rates of penicillin resistance and nonsusceptibility to various antimicrobials in invasive S. pneumoniae isolates). Ankem Derg. 2005 19(1):35-8.
13. Gur D, Mulazimoglu L, Unal S. In vitro susceptibility of S. pneumoniae and S. pyogenes to telithromycin and 11 other antimicrobial agents: Turkish results of e-BASKETT-II surveillance study. Mikrobiyol Bul. 2007;41(1):1-9.
14. Yalcin I, Gurler N, Alhan E, Yaman A, Turgut M, Celik U. Serotype distribution and antibiotic susceptibility of invasive Streptococcus pneumoniae disease isolates from children in Turkey, 2001-2004 Eur J Pediatr. 2006;165(9):954-7.
15. Senol G, Erer OF, Aktogu-Özkan S. Garenoksasinin alt solunum yolu patojenlerine in-vitro etkinligi (In-vitro efficacy of garenoxacin to lower respiratory pathogens). Klimik Derg. 2006;19(1):28-31.
16. Sener B, Tunckanat F, Ulusoy S, Tunger A, Soyletir G, Mulazimoglu L, et al. A survey of antibiotic resistance in Streptococcus pneumoniae and Haemophilus influenzae in Turkey, 2004-2005. J Antimicrob Chemother. 2007.
17. Uncu H, Çolakoglu S, Turunc T, Demiroglu YZ, Aslan H. In vitro resistance rates of S. pneumoniae and H. influenzae clinical isolates to the antibiotics used in therapy. Mikrobiyol Bul. 2007;41(3):441-46.
18. Dilek AR, Korkmaz E, Yilmaz M. Klinik orneklerden izole edilen S. pneumoniae suslarinda penicillin dirend (Pneumococcal penicillin resistance in clinical isolates). FU Sag Bil Derg. 2007;21(3):125-28.
19. Firat M, Ersoy Y, Esel D, Bayraktar M, Caylan R, Durmaz R. Antimicrobial susceptibility and serotype distribution of pneumococci strains isolated from meningitis patients Mikrobiyol Bul. 2006;40(3):169-77.
20. Azap A, Altunsoy A, Memikoglu KA, Balik I. Solunum sistemi infeksiyonlarindan izole edieln pnomokok suslarinin cesitli antibiyotiklere duyarliliklari (The antibiotic susceptibilities of respiratory pneumococcal isolates to various antimicrobials). Ankara Univ Tip Fak Mecm. 2004;57(2):63-7.
21. Oncu S, Erdem H, Pahsa A. Therapeutic options for pneumococcal pneumonia in Turkey. Clin Ther. 2005;27(6):674-83.
22. Woodnutt G, Berry V. Efficacy of high-dose amoxicillin-clavulanate against experimental respiratory tract infections caused by strains of Streptococcus pneumoniae. Antimicrob Agents Chemother. 1999;43(1):35-40.
23. Chidiac C. Acute community-acquired pneumonia. A review of clinical trials. Med Mal Infect 2006;36(11-12).
24. Paris MM, Ramilo O, McCracken GH. Management of meningitis caused by penicillin-resistant Streptococcus pneumoniae. Antimicrob Agents Chemother. 1995;39(10):2171-75.
25. Erdem H, Oncu S, Pahsa A. Antimicrobial therapy in pneumococcal meningitis: an epidemiological assessment from Turkey. Int J Infect Dis 2006;10(3):262-3.
26. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell D, Dean NC. Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults. Clin Infect Dis. 2007;44:S000.
27. Lonks JR. What is the clinical impact of macrolide resistance? Curr Infect Dis Rep. 2004;6:7-12.
28. Clay KD, Hanson JS, Pope SD, Rissmiller RW, Purdum PP, Banks PM. Brief communication: severe hepatotoxicity of telithromycin: three case reports and literature review. Ann Intern Med. 2006;144:415-20.
29. Ak O, Benzonana N, Ozer S, Eraksoy H. Emergence of high-level fluoroquinolone-resistant Streptococcus pneumoniae in Turkey. Int J Infect Dis 2003;7:288-9.
30. Lieberman JM. Appropriate antibiotic use and why it is important: the challenges of bacterial resistance. Pediatr Infect Dis J. 2003;22:1142-51.